In this episode, Dr Rizzo interviews Leah Backhus, MD, MPH, about the role of the thoracic surgeon in lung cancer care, including how the screening environment and the advances in surgical techniques,...
In this video, Paolo Strati, MD, discusses chemotherapy-free approaches in the treatment of patients with indolent b-cell lymphoma, including early trials that are underway on the combination of...
In this video, Mark Roschewski, MD, discusses the key established principles in circulating tumor DNA (ctDNA) in lymphoma, including using ctDNA in prognosis, as a measure of tumor burden, and acting on...
In this Q&A, Jordana B. Cohen, MD, MSCE, assistant professor of medicine and epidemiology at the University of Pennsylvania School of Medicine, and a nephrologist and research scientist at the...
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
In this expert Q&A, Mats Enlund, MD, PhD, discusses his team's study that adds to the growing literature on the impact of general anesthesia choice on overall survival among patients undergoing breast...
09/05/2023
Critical Observations in Pulmonary Medicine, ep. 11
Critical Observations in Pulmonary Medicine, ep. 11
In this episode, Albert Rizzo, MD, interviews Rachel Sanborn, MD, about the multidisciplinary approach to treating patients with lung cancer, including the team of health care providers that treat lung...
Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse.1 In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions about her...
In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...
This video highlights the current guideline recommendations for treating early breast cancer as well as the current guidelines for metastatic breast cancer.
